Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
- Business
- Manufacturing
- Sponsored Content
BPI Contributor
July 20, 2017
20 Min View
Date: Jul 20, 2017
Duration: 20 Min
Sponsored Content
This webcast features: Sibylle Heidelberger, Technical Marketing Manager for Biologics, SCIEX.
Biotherapeutic peptide mapping LC-MS acquisition methods can make it difficult to routinely identify low-level modifications, such as deamidation and oxidation.
This webinar discusses how the use of generic SWATH® Acquisition method on the benchtop X500B QTOF System and BioPharmaView™ Software allows you to confirm the identity of low-level attributes with fast and accurate batch analysis and processing.
She also presents how the use of this unbiased data-independent SWATH® Acquisition method will effectively create a high-quality digital record of a biologic sample for consistent and sensitive detection of low abundance critical quality attributes (CQAs).
You will learn:
How to utilize a simple, generic SWATH® Acquisition method to collect high-quality MS/MS on every detectable peptide in a biologic sample preparation, for confident identification of low level attributes
How to increase the throughput of routine peptide mapping analyses without compromising data quality and sensitivity
How to obtain an unbiased and complete digital record of a biologic sample that can be interrogated or compared with data from other project sites, without the need for sample reanalysis
About the Author(s)
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More